Erik Swain

6 days ago | healio.com | Erik Swain

Key takeaways: An intervention to emphasize weight-related care in primary care settings eliminated weight gain at the population level. The intervention produced extra revenue for clinics with no extra time from clinicians. CHICAGO — An intervention designed to emphasize management of overweight and obesity in primary care settings was associated with population-wide weight loss, researchers reported at the American Diabetes Association Scientific Sessions.

1 week ago | healio.com | Erik Swain

Read more Key takeaways: Orforglipron reduced HbA1c and weight compared with placebo at 40 weeks for patients with type 2 diabetes. Results were similar to phase 3 trials of semaglutide. CHICAGO — Orforglipron, a novel nonpeptide, small molecule oral GLP-1, reduced HbA1c at 40 weeks for patients with type 2 diabetes, according to results of the phase 3 ACHIEVE-1 trial.

1 week ago | healio.com | Erik Swain

Weight loss with tirzepatide sustained for more than 3 years Add topic to email alerts Please provide your email address to receive an email when new articles are posted on Obesity in Endocrinology. Subscribe You've successfully added Obesity in Endocrinology to your alerts. You will receive an email when new content is published. Click Here to Manage Email AlertsBack to Healio We were unable to process your request. Please try again later.

1 week ago | healio.com | Erik Swain

• GLP-1s were linked to reduced risk for major adverse CV and limb events at 1 year in patients with moderate peripheral artery disease. • They were also linked to lower rates of admission and mortality. Among patients with moderate peripheral artery disease, GLP-1 use was associated with reduced risk for cardiovascular and limb events and mortality, researchers reported at the Society for Vascular Surgery Vascular Annual Meeting.

1 week ago | healio.com | Erik Swain

Key takeaways: People with cardiometabolic disorders who ate an overall and healthy plant-based diet had reduced risk for all-cause and heart-related mortality. The effect was greatest in people who ate a healthy plant-based diet. CHICAGO — Among people with cardiometabolic disorders, those who ate a healthy plant-based diet had reduced risk for all-cause and cardiovascular mortality, researchers reported at the American College of Cardiology Scientific Session.